
Ignacio Vieira
Investor interest, technological advances, and collaborations are driving innovation. But the path to innovation is not without challenges. As they develop medicines, growing biotech companies, medical device firms, and large pharmaceutical companies will face financial risks, regulatory changes, supply chain disruptions, and uncertain return on investment.
To seize new growth opportunities while maintaining stability, life sciences companies need to capitalize on data, optimize performance, manage risk, fund growth, and claim R&D tax credits to drive innovation.
BDO’s Life Sciences Consulting practice offers a comprehensive suite of tax, audit, and advisory services to help clients thrive in this evolving space. Our deep industry expertise makes us a valuable catalyst for our clients’ success. Our team, made up of partners and directors from each Advisory area, brings knowledge tailored to the unique nature of life sciences.
In life sciences, scientific and technological advances create opportunities: attracting investors, leveraging growth potential, and competing advantageously. BDO is ready to help companies innovate and grow in this dynamic sector.
FarmaLaboratories, generics, and specialty pharmaceuticals: M&A, PPA, pricing & market access, compliance.
OTC & Consumer HealthGo-to-market, eCommerce, marketing mix, and demand analytics.
BiotechScale-up, financing, partnerships, asset valuation, and regulatory support.
Cosmetics and BeautySupply chain optimization, ESG, omnichannel sales, and international expansion.
Healthcare ProductsManufacturers and distributors: quality, traceability, efficiency, and expansion.
CDMOs & CROsOperations, contracts, data governance, AI, and operational excellence.

